$2.09 billion in sales expected for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) this quarter
Brokers expect Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Rating) to report revenue of $2.09 billion for the current quarter, according to Zacks Investment Research. Seven analysts provided earnings estimates for Vertex…